111, Inc. Executive Summary
Q3 2024 Earnings Webcast
Q3 2024 Earnings Release
Q3 2024 Earnings Presentation
Corporate Profile |
111, Inc. listed on NASDAQ (YI:US) is a leading digital healthcare platform dedicating to digitally connecting patients with drugs and healthcare services in China.
The Company provides millions of consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy 1 Drugstore and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service and patient management service. In addition, the Company's online wholesale pharmacy, 1 Drug Mall, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides omni-channel support to its strategic partners in their drug commercialization effort, with services such as digital marketing, patient education, data analytics and pricing monitoring.
Company Introduction
Primary IR Contact
111, Inc.
E-mail: ir@111.com.cn
If you would like to receive our Investor Relations Packet,
including reprints of scientific publications relating to our products,
click here. Thank you for your interest.